Company profile AURA
After 34 days of this quarter the interest is at 57.0. Based on that we can calculate that during remaining 58 days it will total up to 154.0. Aura Biosciences expected interest is significantly lower compared to same quarter last year (-41.9%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 87 |
| 2019 | 147 69.0% QoQ | 146 -0.7% QoQ | 103 -29.5% QoQ | 152 74.7% YoY 47.6% QoQ |
| 2020 | 60 -59.2% YoY -60.5% QoQ | 75 -48.6% YoY 25.0% QoQ | 109 5.8% YoY 45.3% QoQ | 62 -59.2% YoY -43.1% QoQ |
| 2021 | 77 28.3% YoY 24.2% QoQ | 152 102.7% YoY 97.4% QoQ | 141 29.4% YoY -7.2% QoQ | 345 456.5% YoY 144.7% QoQ |
| 2022 | 114 48.1% YoY -67.0% QoQ | 186 22.4% YoY 63.2% QoQ | 228 61.7% YoY 22.6% QoQ | 265 -23.2% YoY 16.2% QoQ |
| 2023 | 162 42.1% YoY -38.9% QoQ | 166 -10.8% YoY 2.5% QoQ | 221 -3.1% YoY 33.1% QoQ | 57 -78.5% YoY -74.2% QoQ |
The average 5 years interest of Aura Biosciences was 11.75 per week. The last year interest of Aura Biosciences compared to the last 5 years has changed by 30.89%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 38.31%.
Google Trends for Aura Biosciences Aura Biosciences stock
Not enough data for reliable calculations!
There is not enough data for Aura Biosciences Aura Biosciences stock to provide analysis
There is not enough data for Aura Biosciences Aura Biosciences stock to provide correlation calculation
There is not enough data for Aura Biosciences Aura Biosciences stock to provide analysis
After 34 days of this quarter the interest is at 91.0. Based on that we can calculate that during remaining 58 days it will total up to 246.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 34 |
| 2019 | 247 626.5% QoQ | 154 -37.7% QoQ | 54 -64.9% QoQ | 156 358.8% YoY 188.9% QoQ |
| 2020 | 177 -28.3% YoY 13.5% QoQ | 74 -51.9% YoY -58.2% QoQ | 155 187.0% YoY 109.5% QoQ | 64 -59.0% YoY -58.7% QoQ |
| 2021 | 155 -12.4% YoY 142.2% QoQ | 88 18.9% YoY -43.2% QoQ | 181 16.8% YoY 105.7% QoQ | 99 54.7% YoY -45.3% QoQ |
| 2022 | 193 24.5% YoY 94.9% QoQ | 265 201.1% YoY 37.3% QoQ | 140 -22.7% YoY -47.2% QoQ | 382 285.9% YoY 172.9% QoQ |
| 2023 | 200 3.6% YoY -47.6% QoQ | 250 -5.7% YoY 25.0% QoQ | 190 35.7% YoY -24.0% QoQ | 91 -76.2% YoY -52.1% QoQ |
The average 5 years interest of ocular oncology was 12.88 per week. The last year interest of ocular oncology compared to the last 5 years has changed by 37.19%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 52.07%.
After 39 days of this quarter the interest is at 86.0. Based on that we can calculate that during remaining 52 days it will total up to 201.0. urologic oncology expected interest is significantly lower compared to previous quarter (-53.6%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 238 | 201 -15.5% QoQ | 560 178.6% QoQ | 275 -50.9% QoQ |
| 2020 | 207 -13.0% YoY -24.7% QoQ | 314 56.2% YoY 51.7% QoQ | 386 -31.1% YoY 22.9% QoQ | 241 -12.4% YoY -37.6% QoQ |
| 2021 | 218 5.3% YoY -9.5% QoQ | 316 0.6% YoY 45.0% QoQ | 297 -23.1% YoY -6.0% QoQ | 509 111.2% YoY 71.4% QoQ |
| 2022 | 374 71.6% YoY -26.5% QoQ | 362 14.6% YoY -3.2% QoQ | 409 37.7% YoY 13.0% QoQ | 339 -33.4% YoY -17.1% QoQ |
| 2023 | 275 -26.5% YoY -18.9% QoQ | 459 26.8% YoY 66.9% QoQ | 484 18.3% YoY 5.4% QoQ | 433 27.7% YoY -10.5% QoQ |
| 2024 | 86 -68.7% YoY -80.1% QoQ | - | - | - |
The average 5 years interest of urologic oncology was 26.75 per week. The last year interest of urologic oncology compared to the last 5 years has changed by 17.68%. The interest for urologic oncology is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 22.16%.
There is not enough data for choroidal melanoma treatment to provide analysis
There is not enough data for choroidal melanoma treatment to provide correlation calculation
There is not enough data for choroidal melanoma treatment to provide analysis
There is not enough data for virus-like drug conjugates to provide analysis
There is not enough data for virus-like drug conjugates to provide correlation calculation
There is not enough data for virus-like drug conjugates to provide analysis
There is not enough data for AU-011 to provide analysis
There is not enough data for AU-011 to provide correlation calculation
There is not enough data for AU-011 to provide analysis
There is not enough data for primary choroidal melanoma to provide analysis
There is not enough data for primary choroidal melanoma to provide correlation calculation
There is not enough data for primary choroidal melanoma to provide analysis
After 34 days of this quarter the interest is at 76.0. Based on that we can calculate that during remaining 58 days it will total up to 206.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 151 |
| 2019 | 323 113.9% QoQ | 139 -57.0% QoQ | 110 -20.9% QoQ | 137 -9.3% YoY 24.5% QoQ |
| 2020 | 128 -60.4% YoY -6.6% QoQ | 226 62.6% YoY 76.6% QoQ | 245 122.7% YoY 8.4% QoQ | 115 -16.1% YoY -53.1% QoQ |
| 2021 | 204 59.4% YoY 77.4% QoQ | 111 -50.9% YoY -45.6% QoQ | 225 -8.2% YoY 102.7% QoQ | 66 -42.6% YoY -70.7% QoQ |
| 2022 | 183 -10.3% YoY 177.3% QoQ | 152 36.9% YoY -16.9% QoQ | 189 -16.0% YoY 24.3% QoQ | 153 131.8% YoY -19.0% QoQ |
| 2023 | 182 -0.5% YoY 19.0% QoQ | 97 -36.2% YoY -46.7% QoQ | 199 5.3% YoY 105.2% QoQ | 76 -50.3% YoY -61.8% QoQ |
The average 5 years interest of phase III clinical trial was 13.12 per week. The last year interest of phase III clinical trial compared to the last 5 years has changed by -5.87%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -18.7%.
There is not enough data for choroidal metastases to provide analysis
There is not enough data for choroidal metastases to provide correlation calculation
There is not enough data for choroidal metastases to provide analysis
There is not enough data for phase 2 dose-escalation trial to provide analysis
There is not enough data for phase 2 dose-escalation trial to provide correlation calculation
There is not enough data for phase 2 dose-escalation trial to provide analysis
After 39 days of this quarter the interest is at 332.0. Based on that we can calculate that during remaining 52 days it will total up to 775.0. biotechnology company expected interest is significantly higher compared to previous quarter (+44.3%) and same quarter last year (+51.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 181 | 308 70.2% QoQ | 187 -39.3% QoQ | 245 31.0% QoQ |
| 2020 | 511 182.3% YoY 108.6% QoQ | 479 55.5% YoY -6.3% QoQ | 349 86.6% YoY -27.1% QoQ | 413 68.6% YoY 18.3% QoQ |
| 2021 | 586 14.7% YoY 41.9% QoQ | 309 -35.5% YoY -47.3% QoQ | 361 3.4% YoY 16.8% QoQ | 303 -26.6% YoY -16.1% QoQ |
| 2022 | 419 -28.5% YoY 38.3% QoQ | 525 69.9% YoY 25.3% QoQ | 403 11.6% YoY -23.2% QoQ | 336 10.9% YoY -16.6% QoQ |
| 2023 | 511 22.0% YoY 52.1% QoQ | 424 -19.2% YoY -17.0% QoQ | 371 -7.9% YoY -12.5% QoQ | 537 59.8% YoY 44.7% QoQ |
| 2024 | 332 -35.0% YoY -38.2% QoQ | - | - | - |
The average 5 years interest of biotechnology company was 31.0 per week. The last year interest of biotechnology company compared to the last 5 years has changed by 20.42%. The interest for biotechnology company is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 80.08%.
After 39 days of this quarter the interest is at 443.0. Based on that we can calculate that during remaining 52 days it will total up to 1034.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 611 | 976 59.7% QoQ | 853 -12.6% QoQ | 880 3.2% QoQ |
| 2020 | 924 51.2% YoY 5.0% QoQ | 758 -22.3% YoY -18.0% QoQ | 808 -5.3% YoY 6.6% QoQ | 768 -12.7% YoY -5.0% QoQ |
| 2021 | 810 -12.3% YoY 5.5% QoQ | 860 13.5% YoY 6.2% QoQ | 841 4.1% YoY -2.2% QoQ | 883 15.0% YoY 5.0% QoQ |
| 2022 | 1008 24.4% YoY 14.2% QoQ | 1005 16.9% YoY -0.3% QoQ | 929 10.5% YoY -7.6% QoQ | 1005 13.8% YoY 8.2% QoQ |
| 2023 | 1152 14.3% YoY 14.6% QoQ | 1096 9.1% YoY -4.9% QoQ | 1006 8.3% YoY -8.2% QoQ | 1131 12.5% YoY 12.4% QoQ |
| 2024 | 443 -61.5% YoY -60.8% QoQ | - | - | - |
The average 5 years interest of cancer therapy was 71.83 per week. The last year interest of cancer therapy compared to the last 5 years has changed by 15.63%. The interest for cancer therapy is relatively stable and increasing in the last 5 years. The last year interest is quite higher compared to 5 years ago. It has increased by 16.67%.
After 39 days of this quarter the interest is at 349.0. Based on that we can calculate that during remaining 52 days it will total up to 814.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 324 | 608 87.7% QoQ | 438 -28.0% QoQ | 515 17.6% QoQ |
| 2020 | 627 93.5% YoY 21.7% QoQ | 640 5.3% YoY 2.1% QoQ | 546 24.7% YoY -14.7% QoQ | 506 -1.7% YoY -7.3% QoQ |
| 2021 | 670 6.9% YoY 32.4% QoQ | 469 -26.7% YoY -30.0% QoQ | 438 -19.8% YoY -6.6% QoQ | 438 -13.4% YoY 0.0% QoQ |
| 2022 | 804 20.0% YoY 83.6% QoQ | 638 36.0% YoY -20.6% QoQ | 571 30.4% YoY -10.5% QoQ | 710 62.1% YoY 24.3% QoQ |
| 2023 | 788 -2.0% YoY 11.0% QoQ | 622 -2.5% YoY -21.1% QoQ | 604 5.8% YoY -2.9% QoQ | 855 20.4% YoY 41.6% QoQ |
| 2024 | 349 -55.7% YoY -59.2% QoQ | - | - | - |
The average 5 years interest of healthcare sector was 46.59 per week. The last year interest of healthcare sector compared to the last 5 years has changed by 18.22%. The interest for healthcare sector is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 37.77%.
After 39 days of this quarter the interest is at 222.0. Based on that we can calculate that during remaining 52 days it will total up to 518.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 268 | 380 41.8% QoQ | 216 -43.2% QoQ | 353 63.4% QoQ |
| 2020 | 362 35.1% YoY 2.5% QoQ | 308 -18.9% YoY -14.9% QoQ | 327 51.4% YoY 6.2% QoQ | 302 -14.4% YoY -7.6% QoQ |
| 2021 | 336 -7.2% YoY 11.3% QoQ | 338 9.7% YoY 0.6% QoQ | 303 -7.3% YoY -10.4% QoQ | 311 3.0% YoY 2.6% QoQ |
| 2022 | 398 18.5% YoY 28.0% QoQ | 455 34.6% YoY 14.3% QoQ | 395 30.4% YoY -13.2% QoQ | 369 18.6% YoY -6.6% QoQ |
| 2023 | 510 28.1% YoY 38.2% QoQ | 445 -2.2% YoY -12.7% QoQ | 316 -20.0% YoY -29.0% QoQ | 488 32.2% YoY 54.4% QoQ |
| 2024 | 222 -56.5% YoY -54.5% QoQ | - | - | - |
The average 5 years interest of biotechnology industry was 28.36 per week. The last year interest of biotechnology industry compared to the last 5 years has changed by 22.07%. The interest for biotechnology industry is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 29.61%.